scholarly article | Q13442814 |
P50 | author | Xiaofeng Ma | Q48399507 |
Junwei Hao | Q84692261 | ||
Alain R Simard | Q87157423 | ||
P2093 | author name string | Fang Zhang | |
Chao Gao | |||
De-Xin Kong | |||
Rong-Xin Zhang | |||
Xiao-Lin Peng | |||
P2860 | cites work | Hypoxia-regulated lncRNAs in cancer. | Q38580970 |
SIRT1 is decreased during relapses in patients with multiple sclerosis | Q39036784 | ||
HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma | Q39555632 | ||
The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4. | Q42084982 | ||
Expression analysis of the long non-coding RNA antisense to Uchl1 (AS Uchl1) during dopaminergic cells' differentiation in vitro and in neurochemical models of Parkinson's disease | Q42655014 | ||
Significance of mitochondrial reactive oxygen species in the generation of oxidative stress in spermatozoa | Q46585221 | ||
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells. | Q50648416 | ||
The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation | Q61645724 | ||
LincRNA signatures in human lymphocytes | Q86755391 | ||
Multiple sclerosis genetics | Q87928799 | ||
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors | Q22252931 | ||
Environmental risk factors for multiple sclerosis. Part I: The role of infection | Q22252937 | ||
Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis | Q24620427 | ||
Long noncoding RNAs in innate immunity | Q26798082 | ||
Considerations when investigating lncRNA function in vivo. | Q27691450 | ||
Multiple knockout mouse models reveal lincRNAs are required for life and brain development | Q28044579 | ||
A long noncoding RNA mediates both activation and repression of immune response genes | Q28509769 | ||
Long noncoding RNAs with enhancer-like function in human cells | Q29614328 | ||
Co-LncRNA: investigating the lncRNA combinatorial effects in GO annotations and KEGG pathways based on human RNA-Seq data | Q30993174 | ||
Multiple sclerosis: distribution of inflammatory cells in newly forming lesions | Q34089994 | ||
A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation. | Q34375584 | ||
The evolution of lncRNA repertoires and expression patterns in tetrapods | Q34400081 | ||
Expression and functions of long noncoding RNAs during human T helper cell differentiation. | Q35540538 | ||
Analysing the relationship between lncRNA and protein-coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis | Q35867815 | ||
Microarray Profiling and Co-Expression Network Analysis of LncRNAs and mRNAs in Neonatal Rats Following Hypoxic-ischemic Brain Damage | Q36039728 | ||
Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus | Q36291191 | ||
Multiple sclerosis: a complicated picture of autoimmunity. | Q36915907 | ||
Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation | Q37248864 | ||
The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. | Q37519712 | ||
Long noncoding RNAs and human disease | Q37873053 | ||
Macro lncRNAs: a new layer of cis-regulatory information in the mammalian genome | Q38012332 | ||
HOXC9: a key regulator of endothelial cell quiescence and vascular morphogenesis | Q38030247 | ||
Noncoding RNAs and epigenetic mechanisms during X-chromosome inactivation. | Q38226983 | ||
Long non-coding RNAs in the regulation of the immune response | Q38239035 | ||
Pathological mechanisms in progressive multiple sclerosis | Q38378846 | ||
Role of the innate and adaptive immune responses in the course of multiple sclerosis | Q38384621 | ||
Emerging role of long noncoding RNAs in autoimmune diseases. | Q38491550 | ||
Circulating MicroRNA and Long Noncoding RNA as Biomarkers of Cardiovascular Diseases | Q38574032 | ||
P4510 | describes a project that uses | Cytoscape | Q3699942 |
P433 | issue | 4 | |
P921 | main subject | multiple sclerosis | Q8277 |
P304 | page(s) | 298-305 | |
P577 | publication date | 2016-02-04 | |
P1433 | published in | CNS Neuroscience & Therapeutics | Q5013184 |
P1476 | title | Expression Profile of Long Noncoding RNAs in Peripheral Blood Mononuclear Cells from Multiple Sclerosis Patients | |
P478 | volume | 22 |
Q37286350 | A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma |
Q88528129 | Association Study of ANRIL Genetic Variants and Multiple Sclerosis |
Q93111056 | Comprehensive analysis of long non‑coding RNA‑messenger RNA‑microRNA co‑expression network identifies cell cycle‑related lncRNA in hepatocellular carcinoma |
Q57046161 | Detection of lncRNA-mRNA interaction modules by integrating eQTL with weighted gene co-expression network analysis |
Q47887903 | Expression Analysis of Long Non-coding RNAs in the Blood of Multiple Sclerosis Patients |
Q47797228 | HOTAIR but not ANRIL long non-coding RNA contributes to the pathogenesis of multiple sclerosis |
Q58713896 | Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes |
Q38761452 | LncRNAs: macromolecules with big roles in neurobiology and neurological diseases. |
Q47234180 | Long non-coding RNAs in rheumatoid arthritis |
Q91608928 | Long noncoding RNA expression profile from cryptococcal meningitis patients identifies DPY19L1p1 as a new disease marker |
Q89768966 | Long noncoding RNAs APOA1-AS, IFNG-AS1, RMRP and their related biomolecules in Egyptian patients with relapsing-remitting multiple sclerosis: Relation to disease activity and patient disability |
Q59800219 | Noncoding RNAs in multiple sclerosis |
Q64963841 | RNA Expression Profile and Potential Biomarkers in Patients With Spinocerebellar Ataxia Type 3 From Mainland China. |
Q92755064 | Recent advances of long noncoding RNAs involved in the development of multiple sclerosis |
Search more.